Matthew Muto
Optometrist · Boise, IDNPI 1659721314
Payments from drug & device makers
What this record shows
Johnson & Johnson Vision Care, Inc. accounts for 72.6% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2021 at $1,733 and has fallen 91.9% since, to $140 in 2025.
Across 61 payments — averaging $44.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$2K
- Alcon$387
- Bausch & Lomb Americas Inc.$140
- Maculogix, Inc.$51
- Coopervision Inc.$45
- AbbVie$28
- plus $98 from 4 others
What the payments were for
- Consulting fees$1,42852%
- Food & beverage$1,30448%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 25 | $1,983 |
| Alcon | 20 | $387 |
| Bausch & Lomb Americas Inc. | 6 | $140 |
| Maculogix, Inc. | 1 | $51 |
| Coopervision Inc. | 3 | $45 |
| AbbVie | 1 | $28 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $28 |
| Plexus Optix, Inc. | 1 | $26 |
| Kala Pharmaceuticals, Inc. | 1 | $24 |
| Tarsus Pharmaceuticals, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acuvue$1,428
How this compares
$2,732 in reported general payments places this provider in the 85th percentile of 304 optometrist providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cyclosporine | 11 | $3,545 |
| TafluprostTafluprost/Pf | 11 | $1,306 |
| Latanoprost | 63 | $564 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 12 | $360 |
| Timolol Maleate | 20 | $174 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Boise
- Philip RaineyBoise$175K
- Lavar KofoedBoise$91K
- Amber SimonsonBoise$6K
- Brian McNeelBoise$6K
- Erik ThompsonBoise$5K
- Utham BalachandranBoise$4K
- Todd StebelBoise$4K
- Zackary HallBoise$4K
- Dylan HatfieldBoise$4K
- Gregory BodilyBoise$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.